<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">23547970</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1465-542X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2013</Year>
              <Month>Mar</Month>
              <Day>28</Day>
            </PubDate>
          </JournalIssue>
          <Title>Breast cancer research : BCR</Title>
          <ISOAbbreviation>Breast Cancer Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy.</ArticleTitle>
        <Pagination>
          <StartPage>203</StartPage>
          <MedlinePgn>203</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/bcr3401</ELocationID>
        <Abstract>
          <AbstractText>Despite the progress achieved in breast cancer screening and therapeutic innovations, the basal-like subtype of breast cancer (BLBC) still represents a particular clinical challenge. In order to make an impact on survival in this type of aggressive breast cancer, new targeted therapeutic agents are urgently needed. Aberrant activation of the Hedgehog (Hh) signalling pathway has been unambiguously tied to cancer development and progression in a variety of solid malignancies, and the recent approval of vismodegib, an orally bioavailable small-molecule inhibitor of Smoothened, validates Hh signalling as a valuable therapeutic target. A number of recent publications have highlighted a role for Hh signalling in breast cancer models and clinical specimens. Interestingly, Hh ligand overexpression is associated with the BLBC phenotype and a poor outcome in terms of metastasis and breast cancer-related death. In this review, we provide a comprehensive overview of the canonical Hh signalling pathway in mammals, highlight its roles in mammary gland development and breast carcinogenesis and discuss its potential therapeutic value in BLBC.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hui</LastName>
            <ForeName>Mun</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cazet</LastName>
            <ForeName>Aurélie</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nair</LastName>
            <ForeName>Radhika</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watkins</LastName>
            <ForeName>D Neil</ForeName>
            <Initials>DN</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Toole</LastName>
            <ForeName>Sandra A</ForeName>
            <Initials>SA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Swarbrick</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>03</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Breast Cancer Res</MedlineTA>
        <NlmUniqueID>100927353</NlmUniqueID>
        <ISSNLinking>1465-5411</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058990" MajorTopicYN="Y">Molecular Targeted Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23547970</ArticleId>
        <ArticleId IdType="pmc">PMC3672663</ArticleId>
        <ArticleId IdType="doi">10.1186/bcr3401</ArticleId>
        <ArticleId IdType="pii">bcr3401</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. doi: 10.1002/ijc.25516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.25516</ArticleId>
            <ArticleId IdType="pubmed">21351269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Cancer Society. The Global Economic Cost of Cancer. http://www.cancer.org/acs/groups/content/@internationalaffairs/documents/document/acspc-026203.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev. 2008;22:2454–2472. doi: 10.1101/gad.1693608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1693608</ArticleId>
            <ArticleId IdType="pubmed">18794343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullor JL, Sanchez P, Ruiz i Altaba A. Pathways and consequences: Hedgehog signaling in human disease. Trends Cell Biol. 2002;12:562–569. doi: 10.1016/S0962-8924(02)02405-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0962-8924(02)02405-4</ArticleId>
            <ArticleId IdType="pubmed">12495844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng JM, Curran T. The Hedgehog's tale: developing strategies for targeting cancer. Nat Rev Cancer. 2011;11:493–501. doi: 10.1038/nrc3079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc3079</ArticleId>
            <ArticleId IdType="pmc">PMC3576812</ArticleId>
            <ArticleId IdType="pubmed">21614026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol. 2005;6:306–317. doi: 10.1038/nrm1622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm1622</ArticleId>
            <ArticleId IdType="pubmed">15803137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Porter JA, von Kessler DP, Ekker SC, Young KE, Lee JJ, Moses K, Beachy PA. The product of hedgehog autoproteolytic cleavage active in local and long-range signalling. Nature. 1995;374:363–366. doi: 10.1038/374363a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/374363a0</ArticleId>
            <ArticleId IdType="pubmed">7885476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burke R, Nellen D, Bellotto M, Hafen E, Senti KA, Dickson BJ, Basler K. Dispatched, a novel sterol-sensing domain protein dedicated to the release of cholesterol-modified hedgehog from signaling cells. Cell. 1999;99:803–815. doi: 10.1016/S0092-8674(00)81677-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)81677-3</ArticleId>
            <ArticleId IdType="pubmed">10619433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hahn H, Christiansen J, Wicking C, Zaphiropoulos PG, Chidambaram A, Gerrard B, Vorechovsky I, Bale AE, Toftgard R, Dean M, Wainwright B. A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. J Biol Chem. 1996;271:12125–12128. doi: 10.1074/jbc.271.21.12125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.271.21.12125</ArticleId>
            <ArticleId IdType="pubmed">8647801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beachy PA, Hymowitz SG, Lazarus RA, Leahy DJ, Siebold C. Interactions between Hedgehog proteins and their binding partners come into view. Genes Dev. 2010;24:2001–2012. doi: 10.1101/gad.1951710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1951710</ArticleId>
            <ArticleId IdType="pmc">PMC2939362</ArticleId>
            <ArticleId IdType="pubmed">20844013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLellan JS, Zheng X, Hauk G, Ghirlando R, Beachy PA, Leahy DJ. The mode of Hedgehog binding to Ihog homologues is not conserved across different phyla. Nature. 2008;455:979–983. doi: 10.1038/nature07358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature07358</ArticleId>
            <ArticleId IdType="pmc">PMC2679680</ArticleId>
            <ArticleId IdType="pubmed">18794898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Capurro MI, Xu P, Shi W, Li F, Jia A, Filmus J. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev Cell. 2008;14:700–711. doi: 10.1016/j.devcel.2008.03.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2008.03.006</ArticleId>
            <ArticleId IdType="pubmed">18477453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alcedo J, Ayzenzon M, Von Ohlen T, Noll M, Hooper JE. The Drosophila smoothened gene encodes a seven-pass membrane protein, a putative receptor for the hedgehog signal. Cell. 1996;86:221–232. doi: 10.1016/S0092-8674(00)80094-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)80094-X</ArticleId>
            <ArticleId IdType="pubmed">8706127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stecca B, Ruiz IAA. Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol. 2010;2:84–95. doi: 10.1093/jmcb/mjp052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jmcb/mjp052</ArticleId>
            <ArticleId IdType="pmc">PMC2905064</ArticleId>
            <ArticleId IdType="pubmed">20083481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris LG, Samant RS, Shevde LA. Hedgehog signaling: networking to nurture a promalignant tumor microenvironment. Mol Cancer Res. 2011;9:1165–1174. doi: 10.1158/1541-7786.MCR-11-0175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-11-0175</ArticleId>
            <ArticleId IdType="pmc">PMC3175256</ArticleId>
            <ArticleId IdType="pubmed">21775419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huangfu D, Liu A, Rakeman AS, Murcia NS, Niswander L, Anderson KV. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature. 2003;426:83–87. doi: 10.1038/nature02061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature02061</ArticleId>
            <ArticleId IdType="pubmed">14603322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Zaragoza E, Perez-Tavarez R, Ballester A, Lafarga V, Jimenez-Reinoso A, Ramirez A, Murillas R, Gallego MI. Intraepithelial paracrine Hedgehog signaling induces the expansion of ciliated cells that express diverse progenitor cell markers in the basal epithelium of the mouse mammary gland. Dev Biol. 2012;372:28–44. doi: 10.1016/j.ydbio.2012.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2012.09.005</ArticleId>
            <ArticleId IdType="pubmed">23000969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, Epstein EH Jr, Dlugosz AA, Reiter JF. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med. 2009;15:1055–1061. doi: 10.1038/nm.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2011</ArticleId>
            <ArticleId IdType="pmc">PMC2895420</ArticleId>
            <ArticleId IdType="pubmed">19701205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han YG, Kim HJ, Dlugosz AA, Ellison DW, Gilbertson RJ, Alvarez-Buylla A. Dual and opposing roles of primary cilia in medulloblastoma development. Nat Med. 2009;15:1062–1065. doi: 10.1038/nm.2020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2020</ArticleId>
            <ArticleId IdType="pmc">PMC2771737</ArticleId>
            <ArticleId IdType="pubmed">19701203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jenkins D. Hedgehog signalling: emerging evidence for non-canonical pathways. Cell Signal. 2009;21:1023–1034. doi: 10.1016/j.cellsig.2009.01.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2009.01.033</ArticleId>
            <ArticleId IdType="pubmed">19399989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mille F, Thibert C, Fombonne J, Rama N, Guix C, Hayashi H, Corset V, Reed JC, Mehlen P. The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex. Nat Cell Biol. 2009;11:739–746. doi: 10.1038/ncb1880.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1880</ArticleId>
            <ArticleId IdType="pmc">PMC2844407</ArticleId>
            <ArticleId IdType="pubmed">19465923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR, Sterling JA. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res. 2011;71:822–831. doi: 10.1158/0008-5472.CAN-10-2993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-10-2993</ArticleId>
            <ArticleId IdType="pmc">PMC3077118</ArticleId>
            <ArticleId IdType="pubmed">21189326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watson CJ, Khaled WT. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development. 2008;135:995–1003. doi: 10.1242/dev.005439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.005439</ArticleId>
            <ArticleId IdType="pubmed">18296651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michno K, Boras-Granic K, Mill P, Hui CC, Hamel PA. Shh expression is required for embryonic hair follicle but not mammary gland development. Dev Biol. 2003;264:153–165. doi: 10.1016/S0012-1606(03)00401-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0012-1606(03)00401-9</ArticleId>
            <ArticleId IdType="pubmed">14623238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kouros-Mehr H, Werb Z. Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn. 2006;235:3404–3412. doi: 10.1002/dvdy.20978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvdy.20978</ArticleId>
            <ArticleId IdType="pmc">PMC2730892</ArticleId>
            <ArticleId IdType="pubmed">17039550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatsell SJ, Cowin P. Gli3-mediated repression of Hedgehog targets is required for normal mammary development. Development. 2006;133:3661–3670. doi: 10.1242/dev.02542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.02542</ArticleId>
            <ArticleId IdType="pubmed">16914490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis MT, Ross S, Strickland PA, Sugnet CW, Jimenez E, Hui C, Daniel CW. The Gli2 transcription factor is required for normal mouse mammary gland development. Dev Biol. 2001;238:133–144. doi: 10.1006/dbio.2001.0410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/dbio.2001.0410</ArticleId>
            <ArticleId IdType="pubmed">11783999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gritli-Linde A, Hallberg K, Harfe BD, Reyahi A, Kannius-Janson M, Nilsson J, Cobourne MT, Sharpe PT, McMahon AP, Linde A. Abnormal hair development and apparent follicular transformation to mammary gland in the absence of hedgehog signaling. Dev Cell. 2007;12:99–112. doi: 10.1016/j.devcel.2006.12.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2006.12.006</ArticleId>
            <ArticleId IdType="pmc">PMC1885956</ArticleId>
            <ArticleId IdType="pubmed">17199044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moraes RC, Zhang X, Harrington N, Fung JY, Wu MF, Hilsenbeck SG, Allred DC, Lewis MT. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development. 2007;134:1231–1242. doi: 10.1242/dev.02797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.02797</ArticleId>
            <ArticleId IdType="pubmed">17287253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis MT, Ross S, Strickland PA, Sugnet CW, Jimenez E, Scott MP, Daniel CW. Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development. 1999;126:5181–5193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10529434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moraes RC, Chang H, Harrington N, Landua JD, Prigge JT, Lane TF, Wainwright BJ, Hamel PA, Lewis MT. Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation. Development. 2009;136:1423–1432. doi: 10.1242/dev.023994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.023994</ArticleId>
            <ArticleId IdType="pmc">PMC2675781</ArticleId>
            <ArticleId IdType="pubmed">19297414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiaschi M, Rozell B, Bergstrom A, Toftgard R, Kleman MI. Targeted expression of GLI1 in the mammary gland disrupts pregnancy-induced maturation and causes lactation failure. J Biol Chem. 2007;282:36090–36101. doi: 10.1074/jbc.M704280200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M704280200</ArticleId>
            <ArticleId IdType="pubmed">17928300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDermott KM, Liu BY, Tlsty TD, Pazour GJ. Primary cilia regulate branching morphogenesis during mammary gland development. Curr Biol. 2010;20:731–737. doi: 10.1016/j.cub.2010.02.048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cub.2010.02.048</ArticleId>
            <ArticleId IdType="pmc">PMC2916967</ArticleId>
            <ArticleId IdType="pubmed">20381354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. Generation of a functional mammary gland from a single stem cell. Nature. 2006;439:84–88. doi: 10.1038/nature04372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature04372</ArticleId>
            <ArticleId IdType="pubmed">16397499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. Purification and unique properties of mammary epithelial stem cells. Nature. 2006;439:993–997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16395311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanpain C. Tracing the cellular origin of cancer. Nat Cell Biol. 2012;15:126–134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23334500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J, Sharma N, Dekoninck S, Blanpain C. Distinct stem cells contribute to mammary gland development and maintenance. Nature. 2011;479:189–193. doi: 10.1038/nature10573.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10573</ArticleId>
            <ArticleId IdType="pubmed">21983963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R, Mackay A, Grigoriadis A, Tutt A, Ashworth A, Reis-Filho JS, Smalley MJ. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell. 2010;7:403–417. doi: 10.1016/j.stem.2010.07.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2010.07.010</ArticleId>
            <ArticleId IdType="pubmed">20804975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ; kConFab, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009;15:907–913. doi: 10.1038/nm.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2000</ArticleId>
            <ArticleId IdType="pubmed">19648928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006;66:6063–6071. doi: 10.1158/0008-5472.CAN-06-0054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-06-0054</ArticleId>
            <ArticleId IdType="pmc">PMC4386278</ArticleId>
            <ArticleId IdType="pubmed">16778178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiaschi M, Rozell B, Bergstrom A, Toftgard R. Development of mammary tumors by conditional expression of GLI1. Cancer Res. 2009;69:4810–4817. doi: 10.1158/0008-5472.CAN-08-3938.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-08-3938</ArticleId>
            <ArticleId IdType="pmc">PMC2689922</ArticleId>
            <ArticleId IdType="pubmed">19458072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li N, Singh S, Cherukuri P, Li H, Yuan Z, Ellisen LW, Wang B, Robbins D, DiRenzo J. Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells. Stem Cells. 2008;26:1253–1264. doi: 10.1634/stemcells.2007-0691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1634/stemcells.2007-0691</ArticleId>
            <ArticleId IdType="pmc">PMC3778935</ArticleId>
            <ArticleId IdType="pubmed">18292212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, Munchhof M, VanArsdale T, Beachy PA, Reya T. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009;458:776–779. doi: 10.1038/nature07737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature07737</ArticleId>
            <ArticleId IdType="pmc">PMC2946231</ArticleId>
            <ArticleId IdType="pubmed">19169242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santini R, Vinci MC, Penachioni JY, Montagnani V, Olivito B, Gattai R, Pimpinelli N, Gerlini G, Borgognoni L, Stecca B. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells. 2012;30:1808–1818. doi: 10.1002/stem.1160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.1160</ArticleId>
            <ArticleId IdType="pubmed">22730244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park KS, Martelotto LG, Peifer M, Sos ML, Karnezis AN, Mahjoub MR, Bernard K, Conklin JF, Szczepny A, Yuan J, Guo R, Ospina B, Falzon J, Bennett S, Brown TJ, Markovic A, Devereux WL, Ocasio CA, Chen JK, Stearns T, Thomas RK, Dorsch M, Buonamici S, Watkins DN, Peacock CD, Sage J. A crucial requirement for Hedgehog signaling in small cell lung cancer. Nat Med. 2011;17:1504–1508. doi: 10.1038/nm.2473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2473</ArticleId>
            <ArticleId IdType="pmc">PMC3380617</ArticleId>
            <ArticleId IdType="pubmed">21983857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, Ruiz i Altaba A. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med. 2009;1:338–351. doi: 10.1002/emmm.200900039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/emmm.200900039</ArticleId>
            <ArticleId IdType="pmc">PMC3378144</ArticleId>
            <ArticleId IdType="pubmed">20049737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B. Identification of an amplified, highly expressed gene in a human glioma. Science. 1987;236:70–73. doi: 10.1126/science.3563490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.3563490</ArticleId>
            <ArticleId IdType="pubmed">3563490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR, Veelken H, Engelhardt M, Mertelsmann R, Kelleher JF, Schultz P, Warmuth M. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med. 2007;13:944–951. doi: 10.1038/nm1614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1614</ArticleId>
            <ArticleId IdType="pubmed">17632527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Toole SA, Swarbrick A, Sutherland RL. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development. Expert Opin Ther Targets. 2009;13:1095–1103. doi: 10.1517/14728220903130612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14728220903130612</ArticleId>
            <ArticleId IdType="pubmed">19659449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EH Jr, Scott MP. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science. 1997;276:817–821. doi: 10.1126/science.276.5313.817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.276.5313.817</ArticleId>
            <ArticleId IdType="pubmed">9115210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, Menon AG, Warren RS, Chen LC, Scott MP, Epstein EH Jr. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res. 1997;57:2369–2372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9192811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vorechovsky I, Benediktsson KP, Toftgard R. The patched/hedgehog/smoothened signalling pathway in human breast cancer: no evidence for H133Y SHH, PTCH and SMO mutations. Eur J Cancer. 1999;35:711–713. doi: 10.1016/S0959-8049(99)00017-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0959-8049(99)00017-9</ArticleId>
            <ArticleId IdType="pubmed">10505029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V, Zaks TZ, Weber BL. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res. 2005;7:R1186–1198. doi: 10.1186/bcr1356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/bcr1356</ArticleId>
            <ArticleId IdType="pmc">PMC1410746</ArticleId>
            <ArticleId IdType="pubmed">16457699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nessling M, Richter K, Schwaenen C, Roerig P, Wrobel G, Wessendorf S, Fritz B, Bentz M, Sinn HP, Radlwimmer B, Lichter P. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res. 2005;65:439–447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15695385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, Abbott RM, Hoog J, Dooling DJ, Koboldt DC, Schmidt H, Kalicki J, Zhang Q, Chen L, Lin L, Wendl MC, McMichael JF, Magrini VJ, Cook L, McGrath SD, Vickery TL, Appelbaum E, Deschryver K, Davies S, Guintoli T, Lin L. et al.Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature. 2010;464:999–1005. doi: 10.1038/nature08989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature08989</ArticleId>
            <ArticleId IdType="pmc">PMC2872544</ArticleId>
            <ArticleId IdType="pubmed">20393555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S, Katano M. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res. 2004;64:6071–6074. doi: 10.1158/0008-5472.CAN-04-0416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-04-0416</ArticleId>
            <ArticleId IdType="pubmed">15342389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Toole SA, Machalek DA, Shearer RF, Millar EK, Nair R, Schofield P, McLeod D, Cooper CL, McNeil CM, McFarland A, Nguyen A, Ormandy CJ, Qiu MR, Rabinovich B, Martelotto LG, Vu D, Hannigan GE, Musgrove EA, Christ D, Sutherland RL, Watkins DN, Swarbrick A. Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Res. 2011;71:4002–4014. doi: 10.1158/0008-5472.CAN-10-3738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-10-3738</ArticleId>
            <ArticleId IdType="pubmed">21632555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY, Koeffler HP. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Treatment. 2007;105:139–155. doi: 10.1007/s10549-006-9440-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10549-006-9440-4</ArticleId>
            <ArticleId IdType="pubmed">17295047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cui W, Wang LH, Wen YY, Song M, Li BL, Chen XL, Xu M, An SX, Zhao J, Lu YY, Mi XY, Wang EH. Expression and regulation mechanisms of Sonic Hedgehog in breast cancer. Cancer Sci. 2010;101:927–933. doi: 10.1111/j.1349-7006.2010.01495.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1349-7006.2010.01495.x</ArticleId>
            <ArticleId IdType="pubmed">20180807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ten Haaf A, Franken L, Heymann C, von Serenyi S, Cornelissen C, de Hoon JP, Veeck J, Luscher B, Knuchel R, Dahl E. Paradox of sonic hedgehog (SHH) transcriptional regulation: Alternative transcription initiation overrides the effect of downstream promoter DNA methylation. Epigenetics. 2011;6:465–477. doi: 10.4161/epi.6.4.14952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/epi.6.4.14952</ArticleId>
            <ArticleId IdType="pubmed">21372638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pratap J, Wixted JJ, Gaur T, Zaidi SK, Dobson J, Gokul KD, Hussain S, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008;68:7795–7802. doi: 10.1158/0008-5472.CAN-08-1078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-08-1078</ArticleId>
            <ArticleId IdType="pmc">PMC2596479</ArticleId>
            <ArticleId IdType="pubmed">18829534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caserta TM, Kommagani R, Yuan Z, Robbins DJ, Mercer CA, Kadakia MP. p63 overexpression induces the expression of Sonic Hedgehog. Mol Cancer Res. 2006;4:759–768. doi: 10.1158/1541-7786.MCR-05-0149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-05-0149</ArticleId>
            <ArticleId IdType="pubmed">17050669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xuan Y, Lin Z. Expression of Indian Hedgehog signaling molecules in breast cancer. J Cancer Res Clin Oncol. 2009;135:235–240. doi: 10.1007/s00432-008-0451-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00432-008-0451-x</ArticleId>
            <ArticleId IdType="pubmed">18636275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Souzaki M, Kubo M, Kai M, Kameda C, Tanaka H, Taguchi T, Tanaka M, Onishi H, Katano M. Hedgehog signaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer. Cancer Sci. 2011;102:373–381. doi: 10.1111/j.1349-7006.2010.01779.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1349-7006.2010.01779.x</ArticleId>
            <ArticleId IdType="pubmed">21091847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramaswamy B, Lu Y, Teng KY, Nuovo G, Li X, Shapiro CL, Majumder S. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway. Cancer Res. 2012;72:5048–5059. doi: 10.1158/0008-5472.CAN-12-1248.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-12-1248</ArticleId>
            <ArticleId IdType="pmc">PMC3837449</ArticleId>
            <ArticleId IdType="pubmed">22875023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003;425:846–851. doi: 10.1038/nature01972.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature01972</ArticleId>
            <ArticleId IdType="pubmed">14520411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature. 2004;431:707–712. doi: 10.1038/nature02962.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature02962</ArticleId>
            <ArticleId IdType="pubmed">15361885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V, Beermann F, Ruiz IAA. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci USA. 2007;104:5895–5900. doi: 10.1073/pnas.0700776104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0700776104</ArticleId>
            <ArticleId IdType="pmc">PMC1838820</ArticleId>
            <ArticleId IdType="pubmed">17392427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, Nannini-Pepe M, Kotkow K, Marsters JC, Rubin LL, de Sauvage FJ. A paracrine requirement for hedgehog signalling in cancer. Nature. 2008;455:406–410. doi: 10.1038/nature07275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature07275</ArticleId>
            <ArticleId IdType="pubmed">18754008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Tang T, Eastham-Anderson J, Dunlap D, Alicke B, Nannini M, Gould S, Yauch R, Modrusan Z, DuPree KJ, Darbonne WC, Plowman G, de Sauvage FJ, Callahan CA. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci USA. 2011;108:9589–9594. doi: 10.1073/pnas.1017945108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1017945108</ArticleId>
            <ArticleId IdType="pmc">PMC3111273</ArticleId>
            <ArticleId IdType="pubmed">21597001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian H, Callahan CA, DuPree KJ, Darbonne WC, Ahn CP, Scales SJ, de Sauvage FJ. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci USA. 2009;106:4254–4259. doi: 10.1073/pnas.0813203106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0813203106</ArticleId>
            <ArticleId IdType="pmc">PMC2647977</ArticleId>
            <ArticleId IdType="pubmed">19246386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Visbal AP, LaMarca HL, Villanueva H, Li Y, Rosen JM, Lewis MT. Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened. Dev Biol. 2011;352:116–127. doi: 10.1016/j.ydbio.2011.01.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2011.01.025</ArticleId>
            <ArticleId IdType="pmc">PMC3057274</ArticleId>
            <ArticleId IdType="pubmed">21276786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR, Frost AR. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther. 2006;5:674–683. doi: 10.4161/cbt.5.6.2906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cbt.5.6.2906</ArticleId>
            <ArticleId IdType="pmc">PMC1557635</ArticleId>
            <ArticleId IdType="pubmed">16855373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, Neumayer L, Randall RL, Stijleman IJ, Welm BE, Welm AL. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med. 2011;17:1514–1520. doi: 10.1038/nm.2454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2454</ArticleId>
            <ArticleId IdType="pmc">PMC3553601</ArticleId>
            <ArticleId IdType="pubmed">22019887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris LG, Pannell LK, Singh S, Samant RS, Shevde LA. Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61. Oncogene. 2012;31:3370–3380. doi: 10.1038/onc.2011.496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2011.496</ArticleId>
            <ArticleId IdType="pmc">PMC3276742</ArticleId>
            <ArticleId IdType="pubmed">22056874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–890. doi: 10.1016/j.cell.2009.11.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.11.007</ArticleId>
            <ArticleId IdType="pubmed">19945376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, Nieto MA. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 2002;21:3241–3246. doi: 10.1038/sj.onc.1205416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1205416</ArticleId>
            <ArticleId IdType="pubmed">12082640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA. 2007;104:10069–10074. doi: 10.1073/pnas.0703900104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0703900104</ArticleId>
            <ArticleId IdType="pmc">PMC1891217</ArticleId>
            <ArticleId IdType="pubmed">17537911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sterling JA, Oyajobi BO, Grubbs B, Padalecki SS, Munoz SA, Gupta A, Story B, Zhao M, Mundy GR. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. Cancer Res. 2006;66:7548–7553. doi: 10.1158/0008-5472.CAN-06-0452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-06-0452</ArticleId>
            <ArticleId IdType="pubmed">16885353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Das S, Samant RS, Shevde LA. Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis. J Biol Chem. 2011;286:9612–9622. doi: 10.1074/jbc.M110.174920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.174920</ArticleId>
            <ArticleId IdType="pmc">PMC3058990</ArticleId>
            <ArticleId IdType="pubmed">21169638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heller E, Hurchla MA, Xiang J, Su X, Chen S, Schneider J, Joeng KS, Vidal M, Goldberg L, Deng H, Hornick MC, Prior JL, Piwnica-Worms D, Long F, Cagan R, Weilbaecher KN. Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. Cancer Res. 2012;72:897–907. doi: 10.1158/0008-5472.CAN-11-2681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-11-2681</ArticleId>
            <ArticleId IdType="pmc">PMC3659806</ArticleId>
            <ArticleId IdType="pubmed">22186138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Das S, Tucker JA, Khullar S, Samant RS, Shevde LA. Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases. PloS One. 2012;7:e34374. doi: 10.1371/journal.pone.0034374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0034374</ArticleId>
            <ArticleId IdType="pmc">PMC3315536</ArticleId>
            <ArticleId IdType="pubmed">22479615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15894097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271–3277. doi: 10.1200/JCO.2009.25.9820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2009.25.9820</ArticleId>
            <ArticleId IdType="pubmed">20498394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper MK, Porter JA, Young KE, Beachy PA. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science. 1998;280:1603–1607. doi: 10.1126/science.280.5369.1603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.280.5369.1603</ArticleId>
            <ArticleId IdType="pubmed">9616123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipinski RJ, Hutson PR, Hannam PW, Nydza RJ, Washington IM, Moore RW, Girdaukas GG, Peterson RE, Bushman W. Dose-and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouse. Toxicol Sci. 2008;104:189–197. doi: 10.1093/toxsci/kfn076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/toxsci/kfn076</ArticleId>
            <ArticleId IdType="pmc">PMC2927868</ArticleId>
            <ArticleId IdType="pubmed">18411234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ClinicalTrials.gov. http://clinicaltrials.gov/ct2/home</Citation>
        </Reference>
        <Reference>
          <Citation>Dlugosz A, Agrawal S, Kirkpatrick P. Vismodegib. Nat Rev Drug Discovery. 2012;11:437–438. doi: 10.1038/nrd3753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd3753</ArticleId>
            <ArticleId IdType="pmc">PMC3383648</ArticleId>
            <ArticleId IdType="pubmed">22653209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366:2171–2179. doi: 10.1056/NEJMoa1113713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1113713</ArticleId>
            <ArticleId IdType="pmc">PMC5278761</ArticleId>
            <ArticleId IdType="pubmed">22670903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LoRusso PM, Rudin CM, Reddy JC, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Chang I, Darbonne WC, Graham RA, Zerivitz KL, Low JA, Von HoffDD. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res. 2011;17:2502–2511. doi: 10.1158/1078-0432.CCR-10-2745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-10-2745</ArticleId>
            <ArticleId IdType="pmc">PMC5244484</ArticleId>
            <ArticleId IdType="pubmed">21300762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med. 2009;361:1173–1178. doi: 10.1056/NEJMoa0902903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa0902903</ArticleId>
            <ArticleId IdType="pmc">PMC5317279</ArticleId>
            <ArticleId IdType="pubmed">19726761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dijkgraaf GJ, Alicke B, Weinmann L, Januario T, West K, Modrusan Z, Burdick D, Goldsmith R, Robarge K, Sutherlin D, Scales SJ, Gould SE, Yauch RL, de Sauvage FJ. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance. Cancer Res. 2011;71:435–444. doi: 10.1158/0008-5472.CAN-10-2876.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-10-2876</ArticleId>
            <ArticleId IdType="pubmed">21123452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J, Tang JY, Gong R, Kim J, Lee JJ, Clemons KV, Chong CR, Chang KS, Fereshteh M, Gardner D, Reya T, Liu JO, Epstein EH, Stevens DA, Beachy PA. Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer cell. 2010;17:388–399. doi: 10.1016/j.ccr.2010.02.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2010.02.027</ArticleId>
            <ArticleId IdType="pmc">PMC4039177</ArticleId>
            <ArticleId IdType="pubmed">20385363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauth M, Bergstrom A, Shimokawa T, Toftgard R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA. 2007;104:8455–8460. doi: 10.1073/pnas.0609699104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0609699104</ArticleId>
            <ArticleId IdType="pmc">PMC1866313</ArticleId>
            <ArticleId IdType="pubmed">17494766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyman JM, Firestone AJ, Heine VM, Zhao Y, Ocasio CA, Han K, Sun M, Rack PG, Sinha S, Wu JJ, Solow-Cordero DE, Jiang J, Rowitch DH, Chen JK. Smallmolecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc Natl Acad Sci USA. 2009;106:14132–14137. doi: 10.1073/pnas.0907134106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0907134106</ArticleId>
            <ArticleId IdType="pmc">PMC2721821</ArticleId>
            <ArticleId IdType="pubmed">19666565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J, Lee JJ, Kim J, Gardner D, Beachy PA. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc Natl Acad Sci USA. 2010;107:13432–13437. doi: 10.1073/pnas.1006822107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1006822107</ArticleId>
            <ArticleId IdType="pmc">PMC2922148</ArticleId>
            <ArticleId IdType="pubmed">20624968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beauchamp EM, Ringer L, Bulut G, Sajwan KP, Hall MD, Lee YC, Peaceman D, Ozdemirli M, Rodriguez O, Macdonald TJ, Albanese C, Toretsky JA, Uren A. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J Clin Invest. 2011;121:148–160. doi: 10.1172/JCI42874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI42874</ArticleId>
            <ArticleId IdType="pmc">PMC3007144</ArticleId>
            <ArticleId IdType="pubmed">21183792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanton BZ, Peng LF, Maloof N, Nakai K, Wang X, Duffner JL, Taveras KM, Hyman JM, Lee SW, Koehler AN, Chen JK, Fox JL, Mandinova A, Schreiber SL. A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat Chem Biol. 2009;5:154–156. doi: 10.1038/nchembio.142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.142</ArticleId>
            <ArticleId IdType="pmc">PMC2770933</ArticleId>
            <ArticleId IdType="pubmed">19151731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Rückert F, Grützmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M. et al.Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457–1461. doi: 10.1126/science.1171362.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1171362</ArticleId>
            <ArticleId IdType="pmc">PMC2998180</ArticleId>
            <ArticleId IdType="pubmed">19460966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344:783–792. doi: 10.1056/NEJM200103153441101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM200103153441101</ArticleId>
            <ArticleId IdType="pubmed">11248153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, Fernandez-Zapico ME, Hanahan D. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev. 2009;23:24–36. doi: 10.1101/gad.1753809.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1753809</ArticleId>
            <ArticleId IdType="pmc">PMC2632164</ArticleId>
            <ArticleId IdType="pubmed">19136624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenviron ment in restraining cancer progression. Nat Med. 2011;17:320–329. doi: 10.1038/nm.2328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2328</ArticleId>
            <ArticleId IdType="pmc">PMC3569482</ArticleId>
            <ArticleId IdType="pubmed">21383745</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
